208 related articles for article (PubMed ID: 22721900)
1. Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.
Suijkerbuijk AW; Lugnér AK; van Pelt W; Wallinga J; Verhoef LP; de Melker HE; de Wit GA
Vaccine; 2012 Jul; 30(35):5199-205. PubMed ID: 22721900
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
Sartori AM; de Soárez PC; Novaes HM; Amaku M; de Azevedo RS; Moreira RC; Pereira LM; Ximenes RA; Martelli CM
Vaccine; 2012 Dec; 30(52):7489-97. PubMed ID: 23107593
[TBL] [Abstract][Full Text] [Related]
3. Cost-utility of universal hepatitis A vaccination in Canada.
Bauch CT; Anonychuk AM; Pham BZ; Gilca V; Duval B; Krahn MD
Vaccine; 2007 Dec; 25(51):8536-48. PubMed ID: 17996339
[TBL] [Abstract][Full Text] [Related]
4. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
Jacobs RJ; Koff RS; Meyerhoff AS
Am J Gastroenterol; 2002 Feb; 97(2):427-34. PubMed ID: 11866283
[TBL] [Abstract][Full Text] [Related]
6. Cost-benefit analysis of hepatitis a vaccination in Thailand.
Teppakdee A; Tangwitoon A; Khemasuwan D; Tangdhanakanond K; Suramaethakul N; Sriratanaban J; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):118-27. PubMed ID: 12118439
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis A outbreaks: the effect of a mass vaccination programme.
Torner N; Broner S; Martinez A; Godoy P; Batalla J; Dominguez A;
J Viral Hepat; 2011 Apr; 18(4):e1-4. PubMed ID: 21129127
[TBL] [Abstract][Full Text] [Related]
8. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.
Zhou F; Shefer A; Weinbaum C; McCauley M; Kong Y
Vaccine; 2007 May; 25(18):3581-7. PubMed ID: 17306908
[TBL] [Abstract][Full Text] [Related]
9. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA
Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Hepatitis A in Argentina after vaccination.
Vacchino MN
J Viral Hepat; 2008 Oct; 15 Suppl 2():47-50. PubMed ID: 18837834
[TBL] [Abstract][Full Text] [Related]
11. Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.
Martínez A; Broner S; Sala MR; Manzanares-Laya S; Godoy P; Planas C; Minguell S; Torner N; Jané M; Domínguez A; For The Study Of The Immune Status In Health Care TW; Hepatitis A In Catalonia FT
Hum Vaccin Immunother; 2015; 11(1):192-7. PubMed ID: 25483535
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.
Valenzuela MT; Jacobs RJ; Arteaga O; Navarrete MS; Meyerhoff AS; Innis BL
Vaccine; 2005 Jul; 23(32):4110-9. PubMed ID: 15964479
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
15. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program.
Chodick G; Heymann AD; Ashkenazi S; Kokia E; Shalev V
J Viral Hepat; 2008 Oct; 15 Suppl 2():62-5. PubMed ID: 18837837
[TBL] [Abstract][Full Text] [Related]
16. Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands.
Suijkerbuijk AW; Lindeboom R; van Steenbergen JE; Sonder GJ; Doorduyn Y
Eur J Public Health; 2009 Jun; 19(3):240-4. PubMed ID: 19174503
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of hepatitis A vaccination for adults in Belgium.
Luyten J; Van de Sande S; de Schrijver K; Van Damme P; Beutels P
Vaccine; 2012 Sep; 30(42):6070-80. PubMed ID: 22858555
[TBL] [Abstract][Full Text] [Related]
18. The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel.
Chodick G; Green MS; Heymann AD; Rosenmann L; Shalev V
Prev Med; 2007 Nov; 45(5):386-91. PubMed ID: 17599401
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain.
Domínguez A; Oviedo M; Carmona G; Jansá JM; Borrás E; Salleras L; Plasència A
J Viral Hepat; 2008 Oct; 15 Suppl 2():51-6. PubMed ID: 18837835
[TBL] [Abstract][Full Text] [Related]
20. Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008.
Tsou TP; Liu CC; Huang JJ; Tsai KJ; Chang HF
Vaccine; 2011 Apr; 29(16):2956-61. PubMed ID: 21329774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
